All Stories

  1. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...

    Article • The Lancet, October 2025, Elsevier

    Professor Alexandru Corlateanu, Dr Muhammad Shahzad Aslam, Prof. Tomasz M. Karpiński, Xiaodong Sun, Adilson Marques, Dr Priyadarshini Bhattacharjee, Dr Emeka W. Dumbili, Dr Syed Muhammad Yousaf Farooq, Prof. Tabarak Malik, Mohammad Meshbahur Rahman, Prof. Dr Martin Siegel, Kamoru Ademola Adedokun, Dr Khurshid Ahmad, Dr Miyuru Chandradasa, Mr Ukachukwu Okoroafor Abaraogu, Dr MEHNAZ KAMAL, Asrat Agalu Abejew, Dr Mohmmad Khursheed Alam, Dr Manpreet Singh Bhatti, Kathryn H. Jacobsen, Hosam Alzahrani, Prof Dr Mohmed Isaqali Karobari, Dr. Wenping Gong, Felix Nyande, Dr. Olumuyiwa James Peter, Dr Shankar M Bakkannavar, James-Paul Kretchy, Dr Fuad Hamdi Abuadas, Sayan Mitra, Dr Mohammed Kuddus, Dr Amin Mousavi Khaneghah, Dr. Alok Atreya, Professor Richard James Maude, Dr. Mahmoud Nassar, Dr Nazarii Kobyliak, Professor Yousef Khader, Dr. Georgios D Panos

  2. HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients

    Article • Scientific Reports, October 2024, Springer Science + Business Media

    Dr Nazarii Kobyliak

  3. Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma

    Article • Biomedicines, August 2024, MDPI AG

    Dr Nazarii Kobyliak

  4. Corrigendum to: ’Protective effect of vaginal resveratrol administration on joint tissues in ovariectomized rats: Targeting mTOR and сaspase 3’ [Biomed. Pharmacother. (2023) 115176/165]

    Article • Biomedicine & Pharmacotherapy, August 2024, Elsevier

    Dr Nazarii Kobyliak

  5. Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience

    Article • Reviews on Recent Clinical Trials, August 2024, Bentham Science Publishers

    Dr Nazarii Kobyliak

  6. Association between intestinal microflora and obesity

    Article • Minerva Gastroenterology, July 2024, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  7. Digital pathology implementation in cancer diagnostics: towards informed decision-making

    Article • Frontiers in Digital Health, May 2024, Frontiers

    Dr Nazarii Kobyliak

  8. Microbiota substances modulate dendritic cells activity: A critical view

    Article • Heliyon, March 2024, Elsevier

    Dr Nazarii Kobyliak

  9. Probiotic co-supplementation with absorbent smectite for pancreatic beta-cell function in type 2 diabetes: a secondary-data analysis of a randomized double-blind controlled trials

    Article • Frontiers in Endocrinology, February 2024, Frontiers

    Dr Nazarii Kobyliak

  10. Prognostic factors for surgical treatment of prolactin-secreting pituitary adenomas

    Article • Frontiers in Surgery, February 2024, Frontiers

    Dr Nazarii Kobyliak

  11. Ethical navigation of biobanking establishment in Ukraine: learning from the experience of developing countries

    Article • Journal of Medical Ethics, November 2023, BMJ

    Dr Nazarii Kobyliak

  12. Accuracy of attenuation coefficient measurement (ACM) for real-time ultrasound hepatic steatometry: Comparison of simulator/phantom data with magnetic resonance imaging proton density fat fraction (MRI-PDFF)

    Article • Heliyon, October 2023, Elsevier

    Dr Nazarii Kobyliak

  13. Probiotic for Pancreatic β-Cell Function in Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

    Article • Diabetes Therapy, September 2023, Springer Science + Business Media

    Dr Nazarii Kobyliak

  14. Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness

    Article • Critical Reviews in Microbiology, September 2023, Taylor & Francis

    Dr Nazarii Kobyliak

  15. Protective effect of vaginal resveratrol administration on joint tissues in ovariectomized rats: Targeting mTOR and сaspase 3

    Article • Biomedicine & Pharmacotherapy, September 2023, Elsevier

    Dr Nazarii Kobyliak

  16. Antimicrobial activity of dietary supplements based on bacterial lysate of Lactobacillus rhamnosus DV

    Article • Frontiers in Cellular and Infection Microbiology, August 2023, Frontiers

    Dr Nazarii Kobyliak

  17. The detrimental consequences of two consecutive disasters impacting cytopathology in Ukraine: COVID followed by the war

    Article • Cytopathology, April 2023, Wiley

    Dr Nazarii Kobyliak

  18. Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method

    Article • Frontiers in Cellular and Infection Microbiology, February 2023, Frontiers

    Dr Nazarii Kobyliak

  19. Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis

    Article • Frontiers in Immunology, January 2023, Frontiers

    Dr Nazarii Kobyliak

  20. Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: A randomized clinical trial

    Article • Frontiers in Medicine, January 2023, Frontiers

    Dr Nazarii Kobyliak

  21. Fecal Microbiota Transplantation in Diseases Not Associated with Clostridium difficile: Current Status and Future Therapeutic Option

    Article • January 2023, Springer Science + Business Media

    Dr Nazarii Kobyliak

  22. Microbiome and Obesity

    Article • January 2023, Springer Science + Business Media

    Dr Nazarii Kobyliak

  23. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 2022, New England Journal of Medicine (NEJM/MMS)

    Dr Nazarii Kobyliak

  24. Changes in Metabolic Parameters in Patients with Diabetic Kidney Disease Depending on the Status of D3

    Article • Reviews on Recent Clinical Trials, November 2022, Bentham Science Publishers

    Dr Nazarii Kobyliak

  25. Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial

    Article • Frontiers in Medicine, October 2022, Frontiers

    Dr Nazarii Kobyliak

  26. Resveratrol Effects on the Reproductive System in Ovariectomized Rats: Deciphering Possible Mechanisms

    Article • Molecules, August 2022, MDPI AG

    Dr Nazarii Kobyliak

  27. Nutrition program, physical activity and gut microbiota modulation: a randomized controlled trial to promote a healthy lifestyle in students with vitamin D3 deficiency

    Article • Minerva Medica, August 2022, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  28. Precision oncology: ethical challenges and justification

    Article • Minerva Medica, August 2022, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  29. Akkermansia muciniphila as a novel powerful bacterial player in the treatment of metabolic disorders

    Article • Minerva Endocrinology, July 2022, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  30. Response to neoadjuvant chemotherapy in breast cancer: do microRNAs matter?

    Article • Discover Oncology, June 2022, Springer Science + Business Media

    Dr Nazarii Kobyliak

  31. Immune Microenvironment of Muscular-Invasive Urothelial Carcinoma: The Link to Tumor Immune Cycle and Prognosis

    Article • Cells, May 2022, MDPI AG

    Dr Nazarii Kobyliak

  32. Global multi-stakeholder endorsement of the MAFLD definition

    Article • The Lancet Gastroenterology & Hepatology, May 2022, Elsevier

    Dr Feliciano C Paquissi, Professor Sandro Vento, Dr. Francesca Cainelli, Prof. Dr. Mahmoud ElFiky, Dr Arif Mansur Cosar, Dr Amalia Gastaldelli, Dr Nazarii Kobyliak, Prof james O'Beirne

  33. Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment

    Article • World Journal of Hepatology, March 2022, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Nazarii Kobyliak

  34. Correction of Androgen Deficiency in Men with Type 2 Diabetes

    Article • Reviews on Recent Clinical Trials, February 2022, Bentham Science Publishers

    Dr Nazarii Kobyliak, Volodymyr Pankiv

  35. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation

    Article • Medicina, January 2022, MDPI AG

    Dr Nazarii Kobyliak

  36. Gut Microbiota Interactions With Obesity

    Article • January 2022, Elsevier

    Dr Nazarii Kobyliak

  37. SEMI-QUANTITATIVE EVALUATION OF THE HEPATIC AND PANCREATIC STEATOSIS BY GRAY SCALE ECHOGENICITY

    Article • Ultrasound in Medicine & Biology, January 2022, Elsevier

    Dr Nazarii Kobyliak

  38. STRATIFICATION OF LIVER STEATOSIS BY THE ATTENUATION COEFFICIENT MEASUREMENT (ACM) OF THE HAND-HELD ULTRASOUND DEVICE

    Article • Ultrasound in Medicine & Biology, January 2022, Elsevier

    Dr Nazarii Kobyliak

  39. Probiotics and obesity associated disease: an extended view beyond traditional strains

    Article • Minerva Gastroenterology, January 2022, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  40. Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2021, New England Journal of Medicine (NEJM/MMS)

    Dr Nazarii Kobyliak, Professor Vladimir V Rafalskiy

  41. Histological differentiation impacts the tumor immune microenvironment in gastric carcinoma: Relation to the immune cycle

    Article • World Journal of Gastroenterology, August 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Nazarii Kobyliak

  42. Alleviation of halitosis by use of probiotics and their protective mechanisms in the oral cavity

    Article • New Microbes and New Infections, July 2021, Elsevier

    Dr Nazarii Kobyliak

  43. Immunomodulatory role of Faecalibacterium prausnitzii in obesity and metabolic disorders

    Article • Minerva Biotechnology and Biomolecular Research, May 2021, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  44. Microbial and immune markers of patients with metabolic syndrome and cardiovascular diseases: perspectives for early diagnostics

    Article • Minerva Biotechnology and Biomolecular Research, May 2021, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  45. Vitamin D in the prevention and treatment of type-2 diabetes and associated diseases: a critical view during COVID-19 time

    Article • Minerva Biotechnology and Biomolecular Research, May 2021, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  46. Metabolic Benefits of Probiotic Combination with Absorbent Smectite in type 2 Diabetes Patients a Randomised Controlled Trial

    Article • Reviews on Recent Clinical Trials, February 2021, Bentham Science Publishers

    Dr Nazarii Kobyliak, Professor Ludovico Abenavoli, Oleksandr Kovalchuk

  47. Probiotic Composition and Chondroitin Sulfate Regulate TLR-2/4-Mediated NF-κB Inflammatory Pathway and Cartilage Metabolism in Experimental Osteoarthritis

    Article • Probiotics and Antimicrobial Proteins, January 2021, Springer Science + Business Media

    Dr Nazarii Kobyliak

  48. Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial

    Article • Clinical Kidney Journal, January 2021, Oxford University Press (OUP)

    Dr Nazarii Kobyliak

  49. Next generation of strain specific probiotics in diabetes treatment: the case of Prevotella copri

    Article • Minerva Endocrinologica, January 2021, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  50. Hepatic steatosis indices as predictors of vitamin D3 deficiency in patients with NAFLD associated with type 2 diabetes

    Article • Clinical Diabetology, November 2020, VM Media SP. zo.o VM Group SK

    Dr Nazarii Kobyliak

  51. Dietary pattern, colonic microbiota and immunometabolism interaction: new frontiers for diabetes mellitus and related disorders

    Article • Diabetic Medicine, October 2020, Wiley

    Dr Nazarii Kobyliak

  52. Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A randomised controlled trial

    Article • Obesity Medicine, September 2020, Elsevier

    Dr Nazarii Kobyliak

  53. Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes

    Article • Minerva Endocrinologica, September 2020, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  54. Probiotics function and modulation of the immune system in allergic diseases

    Article • Allergologia et Immunopathologia, August 2020, Elsevier

    Dr Nazarii Kobyliak

  55. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment

    Article • Endocrinology and Metabolism, June 2020, Korean Endocrine Society (KAMJE)

    Dr Nazarii Kobyliak

  56. Combined effects of probiotic and chondroprotector during osteoarthritis in rats

    Article • Panminerva Medica, June 2020, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  57. Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

    Article • Diabetes Care, May 2020, American Diabetes Association

    Dr Nazarii Kobyliak

  58. Crosstalk between gut microbiota and osteoarthritis: A critical view

    Article • Journal of Functional Foods, May 2020, Elsevier

    Dr Nazarii Kobyliak

  59. Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial

    Article • Diabetes Obesity and Metabolism, February 2020, Wiley

    Dr Nazarii Kobyliak

  60. New insights on strain-specific impacts of probiotics on insulin resistance: evidence from animal study

    Article • Journal of Diabetes & Metabolic Disorders, February 2020, Springer Science + Business Media

    Dr Nazarii Kobyliak

  61. Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells

    Article • Journal of Gastrointestinal Cancer, November 2019, Springer Science + Business Media

    Dr Nazarii Kobyliak

  62. Probiotics and smectite absorbent gel formulation reduce liver stiffness, transaminase and cytokine levels in NAFLD associated with type 2 diabetes: a randomized clinical study

    Article • Clinical Diabetology, October 2019, VM Media SP. zo.o VM Group SK

    Dr Nazarii Kobyliak

  63. Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

    Article • Diabetes Care, August 2019, American Diabetes Association

    Dr Nazarii Kobyliak

  64. Effect of probiotic on serum cytokines and matrix metalloproteinases profiles during monoiodoacetate-induced osteoarthritis in rats

    Article • Minerva Biotecnologica, May 2019, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  65. Crosstalk between gut microbiota and antidiabetic drug action

    Article • World Journal of Diabetes, March 2019, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Nazarii Kobyliak

  66. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA

    Article • Circulation, January 2019, Wolters Kluwer Health

    Dr Nazarii Kobyliak

  67. Neuropathic diabetic foot ulcers treated with cerium dioxide nanoparticles: A case report

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, January 2019, Elsevier

    Dr Nazarii Kobyliak

  68. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

    Article • JAMA, January 2019, American Medical Association (AMA)

    Dr Nazarii Kobyliak

  69. Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study

    Article • Minerva Medica, December 2018, Edizioni Minerva Medica

    Dr Nazarii Kobyliak

  70. Polyphenol Compounds Melanin Prevented Hepatic Inflammation in Rats with Experimental Obesity

    Article • Natural Product Communications, November 2018, SAGE Publications

    Dr Nazarii Kobyliak

  71. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease

    Article • Pharmaceuticals, October 2018, MDPI AG

    Dr Nazarii Kobyliak, Professor Ludovico Abenavoli

  72. Wpływ Z56822977 na biosyntezę serotoniny w mózgu szczurów z otyłością wywołaną przez podawanie glutaminianu sodu

    Article • Endokrynologia Polska, September 2018, VM Media SP. zo.o VM Group SK

    Dr Nazarii Kobyliak

  73. The correction of the metabolic parameters of msg-induced obesity in rats by 2-[4-(benzyloxy) phenoxy] acetic acid

    Article • Journal of Nutrition & Intermediary Metabolism, September 2018, Elsevier

    Dr Nazarii Kobyliak

  74. Probiotics and nutraceuticals as a new frontier in obesity prevention and management

    Article • Diabetes Research and Clinical Practice, July 2018, Elsevier

    Dr Nazarii Kobyliak

  75. Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, April 2018, Elsevier

    Dr Nazarii Kobyliak

  76. The role of nanotechnology in food safety

    Article • Minerva Biotechnology and Biomolecular Research, April 2018, Edizioni Minerva Medica

    Dr Nazarii Kobyliak, Carmela Colica

  77. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high ca...

    Article • Cardiovascular Diabetology, March 2018, Springer Science + Business Media

    Dr Nazarii Kobyliak

  78. A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial

    Article • Journal of Gastrointestinal and Liver Diseases, March 2018, Romanian Society of Gastroenterology and Heptatology

    Dr Nazarii Kobyliak

  79. Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease

    Article • Annals of Hepatology, December 2017, Index Copernicus

    Dr Nazarii Kobyliak

  80. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders

    Article • Biomedicine & Pharmacotherapy, July 2017, Elsevier

    Dr Nazarii Kobyliak, Professor Dietrich Büsselberg

  81. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats

    Article • Biomedicine & Pharmacotherapy, June 2017, Elsevier

    Dr. Rostyslav V Bubnov, Dr Nazarii Kobyliak, Prof. Luis Rodrigo

  82. H 2 S causes contraction and relaxation of major arteries of the rabbit

    Article • Biomedicine & Pharmacotherapy, May 2017, Elsevier

    Dr Nazarii Kobyliak

  83. Effects of polyphenol compounds melanin on NAFLD/NASH prevention

    Article • Biomedicine & Pharmacotherapy, April 2017, Elsevier

    Dr Nazarii Kobyliak, Olexiy Savchuk, Prof. Luis Rodrigo

  84. The Impact of Hyperglycemia on VEGF Secretion in Retinal Endothelial Cells

    Article • Folia Medica, January 2017, De Gruyter

    Dr Nazarii Kobyliak

  85. Attenuation coefficient measurement as novel real time ultrasound alternative to CAP (fibroscan)

    Article • Journal of Hepatology, January 2017, Elsevier

    Dr Nazarii Kobyliak

  86. Effect of a probiotic on fatty liver index and liver stiffness in NAFLD patients: randomized clinical trial

    Article • Journal of Hepatology, January 2017, Elsevier

    Dr Nazarii Kobyliak

  87. Nanocrystalline cerium dioxide efficacy for prophylaxis of erosive and ulcerative lesions in the gastric mucosa of rats induced by stress

    Article • Biomedicine & Pharmacotherapy, December 2016, Elsevier

    Dr Nazarii Kobyliak, Prof. Luis Rodrigo

  88. Perspectives and challenges of antioxidant therapy for atrial fibrillation

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, November 2016, Springer Science + Business Media

    Dr. Ioana Mozos, Dr Nazarii Kobyliak, Professor Leoné Malan, Prof. Luis Rodrigo

  89. Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer

    Article • Reviews on Recent Clinical Trials, October 2016, Bentham Science Publishers

    Dr Nazarii Kobyliak

  90. Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity

    Article • Probiotics and Antimicrobial Proteins, September 2016, Springer Science + Business Media

    Dr Nazarii Kobyliak

  91. The Role of Liver Biopsy to Assess Alcoholic Liver Disease

    Article • Reviews on Recent Clinical Trials, August 2016, Bentham Science Publishers

    Dr Nazarii Kobyliak

  92. Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles

    Article • Clujul Medical, April 2016, Clujul Medical

    Dr Nazarii Kobyliak

  93. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention

    Article • BMC Gastroenterology, March 2016, Springer Science + Business Media

    Dr Nazarii Kobyliak

  94. Caffeine and cardiovascular diseases: critical review of current research

    Article • Zeitschrift für Ernährungswissenschaft, March 2016, Springer Science + Business Media

    Dr Nazarii Kobyliak

  95. Probiotics in prevention and treatment of obesity: a critical view

    Article • Nutrition & Metabolism, February 2016, Springer Science + Business Media

    Dr Nazarii Kobyliak

  96. Pathophysiological role of host microbiota in the development of obesity

    Article • Nutrition Journal, December 2015, Springer Science + Business Media

    Dr Nazarii Kobyliak

  97. Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition

    Article • Endokrynologia Polska, October 2015, VM Media SP. zo.o VM Group SK

    Dr Nazarii Kobyliak

  98. Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative concept of men health and fertility

    Article • The EPMA Journal, June 2015, Springer Science + Business Media

    Dr Nazarii Kobyliak, Dr. Rostyslav V Bubnov

  99. Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients

    Article • Journal of Diabetes & Metabolic Disorders, May 2015, Springer Science + Business Media

    Dr Nazarii Kobyliak

  100. P0968 : Are the type of probiotic strains and their amount equally effective for NAFLD prevention? Experimental comparative study

    Article • Journal of Hepatology, April 2015, Elsevier

    Dr Nazarii Kobyliak

  101. Diagnosis of experimental stetohepatosis using ultrasound shear wave elastography

    Article • Current Issues in Pharmacy and Medical Sciences, March 2015, Medical University of Lublin

    Dr Nazarii Kobyliak

  102. The Role of Liver Biopsy to Assess Non-Alcoholic Fatty Liver Disease

    Article • Reviews on Recent Clinical Trials, January 2015, Bentham Science Publishers

    Professor Ludovico Abenavoli, Dr Nazarii Kobyliak

  103. Multiprobiotic therapy from childhood prevents the development of nonalcoholic fatty liver disease in adult monosodium glutamate-induced obese rats

    Article • Current Issues in Pharmacy and Medical Sciences, December 2014, De Gruyter

    Dr Nazarii Kobyliak

  104. P269 SHORT-TERM PERIODIC ADMINISTRATION OF MULTIPROBIOTIC FROM CHILDHOOD PREVENTS DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN ADULT MONOSODIUM GLUTAMATE-INDUCED OBESE RATS

    Article • Journal of Hepatology, April 2014, Elsevier

    Dr Nazarii Kobyliak

  105. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Ludovico Abenavoli, Dr Nazarii Kobyliak

  106. Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity

    Article • BMC Complementary and Alternative Medicine, January 2014, Springer Science + Business Media

    Dr Nazarii Kobyliak

  107. Metabolic profile and morpho-functional state of the liver in rats with glutamate-induced obesity

    Article • Current Issues in Pharmacy and Medical Sciences, December 2013, Medical University of Lublin

    Dr Nazarii Kobyliak

  108. 1329 DIAGNOSTIC ACCURACY OF A NEW ELASTOGRAPHIC METHOD (SHEAR WAVE™ ELASTOGRAPHY IMAGING) IN THE NONINVASIVE ASSESSMENT OF NON-ALCOHOLIC STEATOSIS IN PATIENTS WITH TYPE 2 DIABETES

    Article • Journal of Hepatology, April 2013, Elsevier

    Dr Nazarii Kobyliak

  109. 1267 PERFORMANCE OF NEW ULTRASOUND METHOD FOR ASSESSING LIVER STIFFNESS – SHEAR WAVE™ ELASTOGRAPHY IMAGING IN RATS WITH EXPERIMENTAL OBESITY

    Article • Journal of Hepatology, April 2013, Elsevier

    Dr Nazarii Kobyliak